BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32948987)

  • 1. The Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Development of Case Report Forms for Global Use.
    McNett M; Fink EL; Schober M; Mainali S; Helbok R; Robertson CL; Mejia-Mantilla J; Kurtz P; Righy C; Roa JD; Villamizar-Rosales C; Altamirano V; Frontera JA; Maldonado N; Menon D; Suarez J; Chou SHY
    Neurocrit Care; 2020 Dec; 33(3):793-828. PubMed ID: 32948987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Study Design and Rationale.
    Frontera J; Mainali S; Fink EL; Robertson CL; Schober M; Ziai W; Menon D; Kochanek PM; Suarez JI; Helbok R; McNett M; Chou SH;
    Neurocrit Care; 2020 Aug; 33(1):25-34. PubMed ID: 32445105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19-A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium.
    Chou SH; Beghi E; Helbok R; Moro E; Sampson J; Altamirano V; Mainali S; Bassetti C; Suarez JI; McNett M;
    JAMA Netw Open; 2021 May; 4(5):e2112131. PubMed ID: 33974053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
    Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
    J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological manifestations associated with COVID-19: a review and a call for action.
    Leonardi M; Padovani A; McArthur JC
    J Neurol; 2020 Jun; 267(6):1573-1576. PubMed ID: 32436101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes after NeuroCOVID: A 6-month follow-up study on 60 patients.
    Chaumont H; Meppiel E; Roze E; Tressières B; de Broucker T; Lannuzel A;
    Rev Neurol (Paris); 2022; 178(1-2):137-143. PubMed ID: 35000793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 and the Pediatric Nervous System: Global Collaboration to Meet a Global Need.
    Schober ME; Robertson CL; Wainwright MS; Roa JD; Fink EL
    Neurocrit Care; 2021 Oct; 35(2):283-290. PubMed ID: 34184177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations.
    Bonetto V; Pasetto L; Lisi I; Carbonara M; Zangari R; Ferrari E; Punzi V; Luotti S; Bottino N; Biagianti B; Moglia C; Fuda G; Gualtierotti R; Blasi F; Canetta C; Montano N; Tettamanti M; Camera G; Grimoldi M; Negro G; Rifino N; Calvo A; Brambilla P; Biroli F; Bandera A; Nobili A; Stocchetti N; Sessa M; Zanier ER
    Front Immunol; 2022; 13():1070379. PubMed ID: 36591311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).
    Harapan BN; Yoo HJ
    J Neurol; 2021 Sep; 268(9):3059-3071. PubMed ID: 33486564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardizing, harmonizing, and protecting data collection to broaden the impact of COVID-19 research: the rapid acceleration of diagnostics-underserved populations (RADx-UP) initiative.
    Carrillo GA; Cohen-Wolkowiez M; D'Agostino EM; Marsolo K; Wruck LM; Johnson L; Topping J; Richmond A; Corbie G; Kibbe WA
    J Am Med Inform Assoc; 2022 Aug; 29(9):1480-1488. PubMed ID: 35678579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Italian multicenter retrospective-prospective observational study on neurological manifestations of COVID-19 (NEUROCOVID).
    Ferrarese C; Silani V; Priori A; Galimberti S; Agostoni E; Monaco S; Padovani A; Tedeschi G;
    Neurol Sci; 2020 Jun; 41(6):1355-1359. PubMed ID: 32430621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 and Alzheimer's Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future.
    Amadoro G; Latina V; Stigliano E; Micera A
    Cells; 2023 Nov; 12(22):. PubMed ID: 37998336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Worldwide epidemiology of neuro-coronavirus disease in children: lessons for the next pandemic.
    Alcamo AM; McGuire JL; Kanthimathinathan HK; Roa JD; Fink EL
    Curr Opin Pediatr; 2021 Dec; 33(6):580-590. PubMed ID: 34654049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging potential mechanisms and predispositions to the neurological manifestations of COVID-19.
    Jesuthasan A; Massey F; Manji H; Zandi MS; Wiethoff S
    J Neurol Sci; 2021 Sep; 428():117608. PubMed ID: 34391037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis.
    Wang L; Shen Y; Li M; Chuang H; Ye Y; Zhao H; Wang H
    J Neurol; 2020 Oct; 267(10):2777-2789. PubMed ID: 32529575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.
    Dewanjee S; Vallamkondu J; Kalra RS; Puvvada N; Kandimalla R; Reddy PH
    Mol Neurobiol; 2021 Sep; 58(9):4694-4715. PubMed ID: 34169443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myoclonus status revealing COVID 19 infection.
    Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
    Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological presentations of COVID-19: Findings from the Spanish Society of Neurology neuroCOVID-19 registry.
    García-Azorín D; Abildúa MJA; Aguirre MEE; Fernández SF; Moncó JCG; Guijarro-Castro C; Platas MG; Delgado FR; Andrés JML; Ezpeleta D;
    J Neurol Sci; 2021 Apr; 423():117283. PubMed ID: 33636661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.